This blood pressure drug may be safer than the one doctors usually prescribe

Credit: Unsplash+

High blood pressure is a common health problem that affects millions of people around the world.

It’s often called the “silent killer” because it usually doesn’t cause symptoms, but it can lead to serious health issues like heart attacks, strokes, and kidney problems if not treated properly.

A recent study from Geisinger Medical Center has given us new and helpful information about how to treat high blood pressure more safely.

Researchers found that two common types of medications—called ACE inhibitors and ARBs—both work well to lower blood pressure in people who are just starting treatment. But there is a key difference: ARBs seem to cause fewer side effects.

ACE inhibitors and ARBs both help lower blood pressure by relaxing blood vessels, making it easier for blood to flow. They target the same system in the body called the renin-angiotensin-aldosterone system. This system helps control how tight or relaxed our blood vessels are. When the vessels are relaxed, blood pressure goes down.

ACE inhibitors work by blocking a chemical that tells the blood vessels to tighten. ARBs, however, stop that chemical from attaching to the blood vessels in the first place. Even though they act in different ways, both types of medicine help to keep the blood vessels open and reduce blood pressure.

The researchers studied medical records and insurance data from almost 3 million people in the United States, Germany, and South Korea. These people had just begun taking medicine for high blood pressure and did not have other heart problems yet. This gave the researchers a chance to see how each medication worked as a first-time treatment.

What they found was that both types of drugs—ACE inhibitors and ARBs—were equally good at lowering blood pressure. But ARBs were better tolerated, meaning people taking them had fewer side effects. This is important because if a medicine causes side effects, some people may stop taking it, which can be dangerous.

Even though ARBs seem to be safer, doctors often still choose ACE inhibitors as the first option. This could be because they are more familiar with ACE inhibitors, or because they are cheaper or more available. But this study suggests that ARBs could be a better first choice for many patients, especially those who are worried about side effects.

Today, most health experts agree that several types of medicine can be used to treat high blood pressure. These include ACE inhibitors, ARBs, calcium channel blockers, and diuretics. All of them can reduce the risk of serious heart problems. However, choosing the best one often depends on the patient’s age, health, and how they react to the medication.

This new study may help doctors and patients choose the best medicine to start with. It also shows how important it is to consider not only how well a drug works, but also how safe and comfortable it is for the patient.

It’s important to remember that the study looked at people who were new to blood pressure treatment. If someone is already taking medication and doing well, they may not need to change anything. People should always talk to their doctor before making any changes to their medication.

Besides medicine, there are other important ways to control blood pressure. Eating healthy foods, staying active, keeping a healthy weight, and avoiding smoking or too much alcohol can all help. In some cases, these changes alone can reduce the need for medication.

The study was led by RuiJun Chen and published in the journal Hypertension. It reminds us that better health often comes from both good science and smart choices.

If you care about high blood pressure, please read studies that early time-restricted eating could help improve blood pressure, and natural coconut sugar could help reduce blood pressure and artery stiffness.

For more health information, please see recent studies about added sugar in your diet linked to higher blood pressure, and results showing vitamin D could improve blood pressure in people with diabetes.

Copyright © 2025 Knowridge Science Report. All rights reserved.